למיסיל דרמג'ל

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

TERBINAFINE

MAH:

GSK CONSUMER HEALTHCARE, ISRAEL LTD

ATC_code:

D01BA02

pharmaceutical_form:

ג'ל

composition:

TERBINAFINE 1 %

administration_route:

חיצוני

prescription_type:

אין צורך במרשם

manufactured_by:

GSK CONSUMER HEALTHCARE SCHWEIZ AG, SWITZERLAND

therapeutic_group:

TERBINAFINE

therapeutic_area:

TERBINAFINE

therapeutic_indication:

Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g.T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis and Epidemophyton floccosum. Pityriasis ( tinea versicolor due to pityrosporum orbiculare (also known as malassezia furfur).

authorization_date:

2014-12-31

PIL

Pharma code 1335
Gluing area
157.5 mm
11 mm
RECTO
72 mm
210 mm
9 mm
10 mm
10 mm
Order – AWF
Reference
Format
Pharma code
Colour
Font
Minimum font size
Reference MKT
Production site
Reference SITE
Pre-press
LAM DERM 15 G IL 150886_935689Z_PIL
Sonoco-Trident - TR1084632/2/DIS - 06/04/2016
AWF 24763 - OTDC 404578
1335
157.5x210 mm (2 leafes) - PN-P12-V6
NCH Nyon - CH
IL 150886
Proof
PANTONE Reflex Blue U
Outlined - approx 6.7 pt
Outlined
Z
- Recto/Verso